Citation 109879

SANZ,MJ: FERRANDIZ,ML: CEJUDO,M: TERENCIO,MC: GIL,B: BUSTOS,G: UBEDA,A: GUNASEGARAN,R: ALCARAZ,JM:. (1994). INFLUENCE OF A SERIES OF NATURAL FLAVONOIDS ON FREE RADICAL GENERATING SYSTEMS AND OXIDATIVE STRESS.. 24(7)

Citation Details

Title	INFLUENCE OF A SERIES OF NATURAL FLAVONOIDS ON FREE RADICAL GENERATING SYSTEMS AND OXIDATIVE STRESS.
Authors	SANZ,MJ: FERRANDIZ,ML: CEJUDO,M: TERENCIO,MC: GIL,B: BUSTOS,G: UBEDA,A: GUNASEGARAN,R: ALCARAZ,JM:
Year	1994
Volume	24
Issue	7

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN	WEAK ACTIVITY
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN	WEAK ACTIVITY
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN	ACTIVE
4	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN	EQUIVOCAL
5	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN	ACTIVE
6	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN	ACTIVE
7	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN	ACTIVE
8	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN	WEAK ACTIVITY
9	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN-7-O-GLUCURONIDE	WEAK ACTIVITY
10	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN-7-O-GLUCURONIDE	WEAK ACTIVITY
11	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SCUTELLAREIN-7-O-GLUCURONIDE	WEAK ACTIVITY
12	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN-7-O-GLUCURONIDE	WEAK ACTIVITY
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCUTELLAREIN-7-O-GLUCURONIDE	ACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
15	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
17	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	HISPIDULIN	WEAK ACTIVITY
18	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HISPIDULIN	INACTIVE
19	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HISPIDULIN	ACTIVE
20	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	EQUIVOCAL
21	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEPETIN	ACTIVE
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEPETIN	WEAK ACTIVITY
23	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEPETIN	WEAK ACTIVITY
24	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NEPETIN	ACTIVE
25	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NEPETIN	ACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NEPETIN	ACTIVE
27	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NEPETIN	WEAK ACTIVITY
28	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NEPETIN	WEAK ACTIVITY
29	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIFOLIN	WEAK ACTIVITY
30	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIFOLIN	WEAK ACTIVITY
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIFOLIN	WEAK ACTIVITY
32	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TRIFOLIN	WEAK ACTIVITY
33	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TRIFOLIN	ACTIVE
34	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TRIFOLIN	ACTIVE
35	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TRIFOLIN	ACTIVE
36	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HIBIFOLIN	WEAK ACTIVITY
37	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HIBIFOLIN	WEAK ACTIVITY
38	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HIBIFOLIN	WEAK ACTIVITY
39	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	HIBIFOLIN	INACTIVE
40	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HIBIFOLIN	INACTIVE
41	MALONDIALDEHYDE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HIBIFOLIN	INACTIVE
42	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	WEAK ACTIVITY
43	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	ACTIVE
44	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	ACTIVE
45	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	WEAK ACTIVITY
46	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUKUGETIN	WEAK ACTIVITY
47	GLUTAMATE-PYRUVATE-TRANSAMINASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUKUGETIN	ACTIVE
48	HEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	FUKUGETIN	ACTIVE
49	MALONDIALDEHYDE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	FUKUGETIN	ACTIVE

Citation 109879

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1